Preparation for and discontinuation of NS-161’s Phase I trial for inflammatory diseases
A discrete drug development theme involving preparation for and conduct of a Phase I clinical trial of NS-161 for inflammatory diseases, followed by discontinuation.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.